Top-News

PLx Pharma News

Keine aktuellen Kursdaten verfügbar
WKN: A2DMUN
ISIN: US72942A1079
US-Symbol: PLXPQ
Typ: Aktie

PLx Pharma News

20.07.21 - PR Newswire
Thinking about buying stock in Neurobo Pharmaceuticals, Xenetic Biosciences, Amneal Pharmaceuticals, PLx Pharma, or Orbital Energy Group?
Thinking about buying stock in Neurobo Pharmaceuticals, Xenetic Biosciences, Amneal Pharmaceuticals, PLx Pharma, or Orbital Energy Group? PR Newswire
25.05.21 - PR Newswire
Thinking about buying stock in Scopus Biopharma, Verastem, Vistagen, PLx Pharma, or Commercial Vehicle?
Thinking about buying stock in Scopus Biopharma, Verastem, Vistagen, PLx Pharma, or Commercial Vehicle? PR Newswire
30.01.20 - PR Newswire
Protalix BioTherapeutics to Participate in the 16th Annual WORLDSymposium™ 2020
Protalix BioTherapeutics to Participate in the 16th Annual WORLDSymposium™ 2020 Data to be presented in an oral presentation and three poster presentations PR Newswire
25.01.17 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dipexium Pharma - DPRX
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Dipexium Pharma - DPRX PR Newswire
22.12.16 - PR Newswire
Dipexium and PLx Pharma Announce Merger Agreement
Dipexium and PLx Pharma Announce Merger Agreement Merger combines the full resources of both companies behind PLx Pharma's Aspertec™ - an FDA-​approved aspirin product ...
10.11.16 - PR Newswire
Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results
Dipexium Pharmaceuticals Reports Third Quarter 2016 Financial Results PR Newswire
25.10.16 - PR Newswire
Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle Plus Standardized Wound
Dipexium Announces Top-line Data from OneStep Phase 3 Trials with Locilex® in Mild Diabetic Foot Infection Did Not Meet Primary Clinical Endpoint of Superiority Versus Vehicle ...
20.10.16 - PR Newswire
Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®
Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex® PR Newswire
20.10.16 - PR Newswire
Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®
Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex® PR Newswire
20.10.16 - PR Newswire
Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex®
Dipexium Provides Update on Availability of Results from Pivotal Phase 3 Clinical Trials with Locilex® PR Newswire
04.10.16 - PR Newswire
Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise
Dipexium Receives European Medicines Agency Designation as a Small and Medium Enterprise Top-line data from pivotal Phase 3 trials of Locilex in Mild Infections of Diabetic Foot ...
07.09.16 - PR Newswire
Dipexium Pharmaceuticals kündigt Patenterteilung für Locilex® durch die Europäische Union an
Dipexium Pharmaceuticals kündigt Patenterteilung für Locilex® durch die Europäische Union an PR Newswire
07.09.16 - PR Newswire
Dipexium Pharmaceuticals kündigt Patenterteilung für Locilex® durch die Europäische Union an
Dipexium Pharmaceuticals kündigt Patenterteilung für Locilex® durch die Europäische Union an PR Newswire
07.09.16 - PR Newswire
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union PR Newswire
07.09.16 - PR Newswire
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union PR Newswire
07.09.16 - PR Newswire
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union PR Newswire
07.09.16 - PR Newswire
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union
Dipexium Pharmaceuticals Announces Issuance of Locilex® Patent by European Union PR Newswire
28.07.16 - PR Newswire
Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET
Dipexium Pharmaceuticals to Hold Second Quarter 2016 Financial Results Conference Call on Thursday, August 4, 2016, at 8:30 a.m. ET PR Newswire
20.06.16 - PR Newswire
Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference
Dipexium Pharmaceuticals' Locilex® Microbiology Data Presented at ASM Microbe 2016 Conference PR Newswire
16.05.16 - PR Newswire
Dipexium gibt Erreichung des Aufnahmeziels für die klinische OneStep-1-Pivot-Studie der Phase 3 bekannt
Dipexium gibt Erreichung des Aufnahmeziels für die klinische OneStep-1-Pivot-​Studie der Phase 3 bekannt PR Newswire

Newssuche

Videos

09:30 Uhr +23,58%
Technical Trading: S&P 500 Short Chance
S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »